Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.07
EVHC's Cash-to-Debt is ranked lower than
88% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. EVHC: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
EVHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.13 Max: 1.51
Current: 0.07
0.03
1.51
Equity-to-Asset 0.36
EVHC's Equity-to-Asset is ranked lower than
65% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. EVHC: 0.36 )
Ranked among companies with meaningful Equity-to-Asset only.
EVHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.51 Max: 0.8
Current: 0.36
0.31
0.8
Debt-to-Equity 1.00
EVHC's Debt-to-Equity is ranked lower than
67% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 0.57 vs. EVHC: 1.00 )
Ranked among companies with meaningful Debt-to-Equity only.
EVHC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.52 Max: 1.36
Current: 1
0.04
1.36
Interest Coverage 2.25
EVHC's Interest Coverage is ranked lower than
76% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. EVHC: 2.25 )
Ranked among companies with meaningful Interest Coverage only.
EVHC' s Interest Coverage Range Over the Past 10 Years
Min: 2.25  Med: 15.85 Max: 29.05
Current: 2.25
2.25
29.05
Piotroski F-Score: 5
Altman Z-Score: 0.95
Beneish M-Score: -1.32
WACC vs ROIC
3.29%
3.60%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 7.00
EVHC's Operating Margin % is ranked higher than
54% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. EVHC: 7.00 )
Ranked among companies with meaningful Operating Margin % only.
EVHC' s Operating Margin % Range Over the Past 10 Years
Min: 7  Med: 31.19 Max: 35.09
Current: 7
7
35.09
Net Margin % -8.02
EVHC's Net Margin % is ranked lower than
87% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. EVHC: -8.02 )
Ranked among companies with meaningful Net Margin % only.
EVHC' s Net Margin % Range Over the Past 10 Years
Min: -8.02  Med: 6.92 Max: 8.52
Current: -8.02
-8.02
8.52
ROE % -10.21
EVHC's ROE % is ranked lower than
88% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. EVHC: -10.21 )
Ranked among companies with meaningful ROE % only.
EVHC' s ROE % Range Over the Past 10 Years
Min: -10.21  Med: 9.45 Max: 11.71
Current: -10.21
-10.21
11.71
ROA % -3.74
EVHC's ROA % is ranked lower than
84% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. EVHC: -3.74 )
Ranked among companies with meaningful ROA % only.
EVHC' s ROA % Range Over the Past 10 Years
Min: -3.74  Med: 3.56 Max: 6.44
Current: -3.74
-3.74
6.44
ROC (Joel Greenblatt) % 23.74
EVHC's ROC (Joel Greenblatt) % is ranked higher than
70% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 16.07 vs. EVHC: 23.74 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
EVHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.74  Med: 124.8 Max: 235.67
Current: 23.74
23.74
235.67
3-Year Revenue Growth Rate 23.70
EVHC's 3-Year Revenue Growth Rate is ranked higher than
91% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. EVHC: 23.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
EVHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 9.6  Med: 15.4 Max: 23.7
Current: 23.7
9.6
23.7
3-Year EBITDA Growth Rate -7.90
EVHC's 3-Year EBITDA Growth Rate is ranked lower than
78% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. EVHC: -7.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
EVHC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9  Med: 12.3 Max: 40.5
Current: -7.9
-9
40.5
GuruFocus has detected 4 Warning Signs with Envision Healthcare Corp $EVHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» EVHC's 30-Y Financials

Financials (Next Earnings Date: 2017-11-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

EVHC Guru Trades in Q3 2016

Mario Gabelli 30,000 sh (New)
Jeremy Grantham 2,429,000 sh (New)
Vanguard Health Care Fund 10,993,895 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Andreas Halvorsen 3,419,495 sh (-56.26%)
Jim Simons 227,900 sh (-67.23%)
» More
Q4 2016

EVHC Guru Trades in Q4 2016

Paul Tudor Jones 21,316 sh (New)
Jim Simons 303,972 sh (+33.38%)
Mario Gabelli 21,717 sh (-27.61%)
Andreas Halvorsen 1,804,445 sh (-47.23%)
Vanguard Health Care Fund 4,723,860 sh (-57.03%)
Jeremy Grantham 61,024 sh (-97.49%)
» More
Q1 2017

EVHC Guru Trades in Q1 2017

Steven Cohen 404,978 sh (New)
Lee Ainslie 3,065,266 sh (New)
Mario Gabelli 27,517 sh (+26.71%)
Vanguard Health Care Fund 4,942,595 sh (+4.63%)
Jeremy Grantham 61,024 sh (unchged)
Andreas Halvorsen Sold Out
Jim Simons Sold Out
Paul Tudor Jones 15,775 sh (-25.99%)
» More
Q2 2017

EVHC Guru Trades in Q2 2017

David Dreman 7,073 sh (New)
Lee Ainslie 5,093,292 sh (+66.16%)
Mario Gabelli 34,017 sh (+23.62%)
Vanguard Health Care Fund 4,942,595 sh (unchged)
Jeremy Grantham Sold Out
Paul Tudor Jones 4,829 sh (-69.39%)
Steven Cohen 15,000 sh (-96.30%)
» More
» Details

Insider Trades

Latest Guru Trades with EVHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2017-06-30 Add 23.62%$54.54 - $63.36 $ 44.16-23%34,017
David Dreman 2017-06-30 New Buy0.24%$54.54 - $63.36 $ 44.16-23%7,073
Vanguard Health Care Fund 2017-03-31 Add 4.63%0.03%$61.32 - $72.48 $ 44.16-34%4,942,595
Mario Gabelli 2017-03-31 Add 26.71%$61.32 - $72.48 $ 44.16-34%27,517
Vanguard Health Care Fund 2016-12-31 Reduce -57.03%0.3%$58.16 - $71.75 $ 44.16-33%4,723,860
Mario Gabelli 2016-12-31 Reduce -27.61%$58.16 - $71.75 $ 44.16-33%21,717
Mario Gabelli 2016-09-30 New Buy$20.63 - $26.44 $ 44.1692%30,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Envision Healthcare Corp

SymbolPriceYieldDescription
EVHCPR113.734.625 1/4 % Mand Conv Pfd Shs Series -A-1-

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621111    SIC: 8011
Compare:NYSE:HLS, NAS:WOOF, NAS:ACHC, NYSE:MD, NYSE:CHE, NYSE:SEM, NAS:LPNT, NYSE:AMN, NAS:AMED, NYSE:THC, NAS:TVTY, NAS:LHCG, NYSE:UHS, NYSE:CYH, NYSE:USPH, NAS:PRSC, NAS:AFAM, NAS:SGRY, NAS:ADUS, NAS:BIOS » details
Traded in other countries:N16.Germany,
Headquarter Location:USA
Envision Healthcare Corp is a provider of healthcare services. It offers physician-led services, medical transportation services and ambulatory services.

AmSurg acquires and develops practice-based ambulatory surgery centers in partnership with physician groups. The company has a majority interest in 206 surgery centers in 33 states. AmSurg centers are typically single-specialty and perform procedures in the areas of gastroenterology, ophthalmology, and orthopedics.

Top Ranked Articles about Envision Healthcare Corp

Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Envision Healthcare Corporation Shareholders – EVHC
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Envision Healthcare Corporation Shareholders and a Lead Plaintiff Deadline of October 3, 2017
Safirstein Metcalf LLP Announces that A Class Action Has Been Filed Against Envision Healthcare Corporation – EVHC
EVHC LOSS NOTICE: Rosen Law Firm Reminds Envision Healthcare Corporation Investors of Important Deadline in Class Action – EVHC
EVHC INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Envision Healthcare Corporation and a Lead Plaintiff Deadline of October 3, 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Envision Healthcare Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 3, 2017 – EVHC
Lifshitz & Miller LLP Announces Investigation of Applied Optoelectronics, Inc., Envision Healthcare Corporation, Lexmark International, Inc., MAXIMUS, Inc., Quanta Services, Inc., TechnipFMC plc and Zebra Technologies Corporation
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision Healthcare Corporation and Reminds Investors with Losses to Contact the Firm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Envision Healthcare Corporation of Class Action Lawsuit and Upcoming Deadline – EVHC
IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Envision Healthcare Corporation and Reminds Investors with Losses to Contact the Firm

Ratios

vs
industry
vs
history
Forward PE Ratio 10.73
EVHC's Forward PE Ratio is ranked higher than
66% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 21.05 vs. EVHC: 10.73 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 0.82
EVHC's PB Ratio is ranked higher than
84% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. EVHC: 0.82 )
Ranked among companies with meaningful PB Ratio only.
EVHC' s PB Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.59 Max: 2.61
Current: 0.82
0.8
2.61
PS Ratio 0.67
EVHC's PS Ratio is ranked higher than
72% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. EVHC: 0.67 )
Ranked among companies with meaningful PS Ratio only.
EVHC' s PS Ratio Range Over the Past 10 Years
Min: 0.66  Med: 1.22 Max: 1.75
Current: 0.67
0.66
1.75
Price-to-Free-Cash-Flow 8.41
EVHC's Price-to-Free-Cash-Flow is ranked higher than
80% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. EVHC: 8.41 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
EVHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.91  Med: 4.9 Max: 16.27
Current: 8.41
1.91
16.27
Price-to-Operating-Cash-Flow 6.34
EVHC's Price-to-Operating-Cash-Flow is ranked higher than
72% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 15.16 vs. EVHC: 6.34 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
EVHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.75  Med: 4.42 Max: 11.23
Current: 6.34
1.75
11.23
EV-to-EBIT 28.16
EVHC's EV-to-EBIT is ranked lower than
77% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 20.05 vs. EVHC: 28.16 )
Ranked among companies with meaningful EV-to-EBIT only.
EVHC' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.5  Med: 7.2 Max: 36.3
Current: 28.16
3.5
36.3
EV-to-EBITDA 16.41
EVHC's EV-to-EBITDA is ranked lower than
69% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 15.41 vs. EVHC: 16.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
EVHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.2  Med: 6.5 Max: 23.1
Current: 16.41
3.2
23.1
EV-to-Revenue 1.97
EVHC's EV-to-Revenue is ranked lower than
60% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. EVHC: 1.97 )
Ranked among companies with meaningful EV-to-Revenue only.
EVHC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2  Med: 2 Max: 3.9
Current: 1.97
1.2
3.9
Shiller PE Ratio 33.01
EVHC's Shiller PE Ratio is ranked lower than
71% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 29.00 vs. EVHC: 33.01 )
Ranked among companies with meaningful Shiller PE Ratio only.
EVHC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.58  Med: 23.9 Max: 51.3
Current: 33.01
12.58
51.3
Current Ratio 2.83
EVHC's Current Ratio is ranked higher than
88% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. EVHC: 2.83 )
Ranked among companies with meaningful Current Ratio only.
EVHC' s Current Ratio Range Over the Past 10 Years
Min: 1.39  Med: 3.2 Max: 4.94
Current: 2.83
1.39
4.94
Quick Ratio 2.82
EVHC's Quick Ratio is ranked higher than
88% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. EVHC: 2.82 )
Ranked among companies with meaningful Quick Ratio only.
EVHC' s Quick Ratio Range Over the Past 10 Years
Min: 1.34  Med: 3.01 Max: 4.62
Current: 2.82
1.34
4.62
Days Inventory 51.00
EVHC's Days Inventory is ranked lower than
82% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 15.65 vs. EVHC: 51.00 )
Ranked among companies with meaningful Days Inventory only.
EVHC' s Days Inventory Range Over the Past 10 Years
Min: 11  Med: 41.82 Max: 74.33
Current: 51
11
74.33
Days Sales Outstanding 81.80
EVHC's Days Sales Outstanding is ranked lower than
92% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. EVHC: 81.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
EVHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.64  Med: 41.22 Max: 173.32
Current: 81.8
35.64
173.32
Days Payable 103.55
EVHC's Days Payable is ranked higher than
69% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. EVHC: 103.55 )
Ranked among companies with meaningful Days Payable only.
EVHC' s Days Payable Range Over the Past 10 Years
Min: 18.67  Med: 65.08 Max: 182.32
Current: 103.55
18.67
182.32

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -53.70
EVHC's 3-Year Average Share Buyback Ratio is ranked lower than
94% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. EVHC: -53.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
EVHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -53.7  Med: -1.8 Max: 1.2
Current: -53.7
-53.7
1.2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.51
EVHC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
90% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 1.97 vs. EVHC: 0.51 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
EVHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.24  Med: 0.6 Max: 2.18
Current: 0.51
0.24
2.18
Price-to-Median-PS-Value 0.55
EVHC's Price-to-Median-PS-Value is ranked higher than
78% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. EVHC: 0.55 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
EVHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 1.13 Max: 2.31
Current: 0.55
0.54
2.31
Earnings Yield (Greenblatt) % 3.55
EVHC's Earnings Yield (Greenblatt) % is ranked lower than
61% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.84 vs. EVHC: 3.55 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
EVHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 13.9 Max: 28.5
Current: 3.55
2.8
28.5
Forward Rate of Return (Yacktman) % 20.99
EVHC's Forward Rate of Return (Yacktman) % is ranked higher than
75% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.98 vs. EVHC: 20.99 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
EVHC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 15.1  Med: 25.8 Max: 58.7
Current: 20.99
15.1
58.7

More Statistics

Revenue (TTM) (Mil) $6,038.42
EPS (TTM) $ -5.22
Beta0.21
Short Percentage of Float13.27%
52-Week Range $43.10 - 74.75
Shares Outstanding (Mil)120.83

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 7,864 8,360
EPS ($) 3.49 4.02
EPS without NRI ($) 3.49 4.02
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for EVHC

Headlines

Articles On GuruFocus.com
Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Envision Healthcare Corporation Sharehold Sep 15 2017 
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Envision Healthcare Corpor Sep 12 2017 
Safirstein Metcalf LLP Announces that A Class Action Has Been Filed Against Envision Healthcare Corp Sep 11 2017 
EVHC LOSS NOTICE: Rosen Law Firm Reminds Envision Healthcare Corporation Investors of Important Dead Sep 08 2017 
EVHC INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving E Sep 06 2017 
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Envision Healthcare Corporation of a C Sep 05 2017 
Lifshitz & Miller LLP Announces Investigation of Applied Optoelectronics, Inc., Envision Healthcare Aug 30 2017 
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision Aug 28 2017 
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Env Aug 26 2017 
IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Envision Hea Aug 25 2017 

More From Other Websites
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class... Sep 20 2017
Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Envision Healthcare... Sep 20 2017
Do We Need To Worry About Healthcare Reform Yet Again? Sep 20 2017
Envision Healthcare Makes Organizational Changes, Here's Why Sep 20 2017
The Biggest Loser: Envision Healthcare Slumps 9.6% Sep 19 2017
DEADLINE APPROACHING: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision... Sep 19 2017
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Envision Healthcare Corporation of a... Sep 19 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Sep 19 2017
ENVISION HEALTHCARE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding... Sep 18 2017
Envision Healthcare Announces $250 Million Stock Repurchase Sep 18 2017
Envision Healthcare Announces Organizational Changes to Align Senior Leadership Structure with... Sep 18 2017
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Envision... Sep 18 2017
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Envision... Sep 18 2017
DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision... Sep 15 2017
EVHC EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Sep 15 2017
Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Envision Healthcare Corporation... Sep 15 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Sep 14 2017
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Envision Healthcare... Sep 14 2017
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Envision Healthcare Corporation of... Sep 14 2017
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision... Sep 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}